WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4.95 Cr | ₹3.95 Cr | ₹3.44 Cr | ₹0.21 Cr | ₹3.59 Cr |
What is the latest Total Non-Current Liabilities ratio of WINDLAS BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹4.95 Cr |
| Mar2024 | ₹3.95 Cr |
| Mar2023 | ₹3.44 Cr |
| Mar2022 | ₹0.21 Cr |
| Mar2021 | ₹3.59 Cr |
How is Total Non-Current Liabilities of WINDLAS BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.95 Cr | 25.46 | |
| Mar2024 | ₹3.95 Cr | 14.84 | |
| Mar2023 | ₹3.44 Cr | 1,513.62 | |
| Mar2022 | ₹0.21 Cr | -94.06 | |
| Mar2021 | ₹3.59 Cr | - | |
Compare Total Non-Current Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,585.1 Cr | -3.4% | 1.5% | -21.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -3.4% |
1.5% |
-21.8% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses